Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli

BACKGROUND: The presence of terminal, surface-exposed sialic acid moieties can greatly enhance the in vivo half-life of glycosylated biopharmaceuticals and improve their therapeutic efficacy. Complete and homogeneous sialylation of glycoproteins can be efficiently performed enzymically in vitro but...

Descripción completa

Detalles Bibliográficos
Autores principales: Skretas, Georgios, Carroll, Sean, DeFrees, Shawn, Schwartz, Marc F, Johnson, Karl F, Georgiou, George
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762462/
https://www.ncbi.nlm.nih.gov/pubmed/19788761
http://dx.doi.org/10.1186/1475-2859-8-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762462/
https://www.ncbi.nlm.nih.gov/pubmed/19788761
http://dx.doi.org/10.1186/1475-2859-8-50

Ejemplares similares